Skip to main content
. 2016 Aug 4;5(4):488–490. doi: 10.3892/mco.2016.981

Figure 4.

Figure 4.

Chest computed tomography scan (A) 1 month after discontinuation of erlotinib and prior to the initiation of afatinib and prednisolone and (B) after combination treatment with afatinib and predonisolone. The treatment decreased the size of the primary tumor (upper panel) and improved carcinomatous lymphangitis (lower panel).